India’s customs department recently stepped up its scrutiny of pharmaceutical raw materials imported from China after several, including those for drugs such as paracetamol and antibiotics, saw 35-40% average price increases, and a military face-off with China led to calls for the rejection of goods manufactured in the country.
After a hand-to-hand skirmish between Indian and Chinese soldiers on 15 June led to fatalities, the Indian government banned 59...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
